Inflammation and stress-response pathways are implicated in tumor progression, with NF-κB, interleukin-8 (IL-8), and heat shock proteins (HSP90α/β) playing key roles in survival signaling and treatment resistance. This evidence concerns the gene NFKB1 and neoplasm.